Immunity Against Cocaine High

  • Author: ChemistryViews
  • Published: 06 January 2011
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Molecular Therapy/Nature Publishing Group
thumbnail image: Immunity Against Cocaine High

A team led by Ronald Crystal, Weill Cornell Medical College, USA, have covalently linking a cocaine analog to the capsid proteins of a noninfectious adenovirus, a common cold virus, to produce a long-lasting vaccine against the high of cocaine.


The vaccine suppresses the stimulant effects of the drug by preventing cocaine from reaching the brain rather than interfering with the neurological targets of the drug. The vaccine has been tested on mice and the effect was seen to last for at least 13 weeks, the longest time point evaluated in such an approach.


Since the vaccine will not require multiple expensive infusions, the researchers hope that it can move quickly into human trials. The approach could also be useful in treating other addictions, such as to nicotine, heroin, and methamphetamine.


Article Views: 5418

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH